FEDERATED HERMES, INC. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$1,097,231
+18187.2%
67,940
+79829.4%
0.00%
Q2 2022$6,000
-99.9%
85
-99.9%
0.00%
-100.0%
Q1 2021$9,494,000
-42.6%
71,825
-24.9%
0.02%
-47.1%
Q4 2020$16,546,000
+125.7%
95,622
+45.2%
0.03%
+100.0%
Q3 2020$7,330,000
+1045.3%
65,848
+766.5%
0.02%
+1600.0%
Q4 2019$640,000
-92.6%
7,599
-93.5%
0.00%
-95.2%
Q3 2019$8,685,000
+9998.8%
116,141
+8389.8%
0.02%
Q2 2019$86,000
-97.0%
1,368
-97.7%
0.00%
-100.0%
Q1 2019$2,835,000
+283400.0%
58,862
+367787.5%
0.01%
Q4 2018$1,000
-100.0%
16
-100.0%
0.00%
-100.0%
Q3 2018$9,402,000
+148.0%
179,437
+48.2%
0.02%
+100.0%
Q2 2018$3,791,000
+379000.0%
121,118
+242136.0%
0.01%
Q1 2018$1,000
-50.0%
50
-47.9%
0.00%
Q4 2017$2,0000.0%96
-8.6%
0.00%
Q3 2017$2,0000.0%105
-7.1%
0.00%
Q2 2017$2,000
-99.5%
113
-99.8%
0.00%
-100.0%
Q4 2016$393,000
-8.0%
50,0000.0%0.00%0.0%
Q3 2016$427,000
-26.9%
50,0000.0%0.00%
-50.0%
Q2 2016$584,000
-19.3%
50,0000.0%0.00%0.0%
Q1 2016$724,000
+7.9%
50,000
+66.7%
0.00%0.0%
Q4 2015$671,00030,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders